Jpmorgan Chase & CO Age X Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Dec 26, 2024	BUY	$0.33 - $0.74 $677 - $1,519	2,054 New	2,054 $0
Q4 2023 Feb 12, 2024	BUY	$0.33 - $0.74 $4 - $11	15 Added 0.74%	2,054 $0
Q3 2023 Nov 14, 2023	BUY	$0.67 - $0.85 $16 - $21	25 Added 1.24%	2,039 $1,000
Q2 2023 Aug 11, 2023	BUY	$0.45 - $0.89 $900 - $1,780	2,000 Added 14285.71%	2,014 $1,000
Q3 2021 Nov 12, 2021	BUY	$0.93 - $1.54 $13 - $21	14 New	14 $0

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.